Compare $CBIO vs $CLYM | Chartloom

Compare

$CBIO vs $CLYM

Crescent Biopharma Inc · Climb Bio Inc

CBIO

Crescent Biopharma Inc

CLYM

Climb Bio Inc

Compare $CBIO vs $CLYM

Comparing Crescent Biopharma Inc and Climb Bio Inc

CBIOCrescent Biopharma Inc

CLYMClimb Bio Inc

CBIOCrescent Biopharma Inc

Market cap

$532M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

34.6%

52W performance

23.6%

FCF yield

-28.9%

CLYMClimb Bio Inc

Market cap

$630M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

193.3%

52W performance

511.1%

FCF yield

-8.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CBIO

CLYM

Detailed metrics comparison

CBIO

Crescent Biopharma Inc

CLYM

Climb Bio Inc

Market Cap

CBIO$532M

CLYM$630M

Enterprise Value

CBIO$360M

CLYM$586M

Price

CBIO$14.91

CLYM$11.00

P/E Ratio

CBION/A

CLYMN/A

P/S Ratio

CBIO44.76x

CLYM0.00x

EV/Sales

CBIO30.32x

CLYM0.00x

EV/EBITDA

CBIO0.00x

CLYM0.00x

P/B Ratio

CBIO3.26x

CLYM2.62x

P/FCF Ratio

CBION/A

CLYMN/A

EV/FCF

CBIO-2.35x

CLYM-11.04x

PEG Ratio

CBION/A

CLYMN/A

Forward P/E (NTM)

CBION/A

CLYMN/A

Forward P/S (NTM)

CBION/A

CLYMN/A

Revenue (TTM)

CBIO$12M

CLYM$0

Revenue Growth (YoY)

CBION/A

CLYMN/A

Forward Rev Growth

CBIO-15.7%

CLYM27.3%

Gross Margin (TTM)

CBIO0.0%

CLYM0.0%

Operating Margin (TTM)

CBIO0.0%

CLYM0.0%

EBITDA Margin (TTM)

CBIO-1355.3%

CLYM0.0%

Net Margin (TTM)

CBIO-1406.4%

CLYM0.0%

FCF Margin (TTM)

CBIO-1292.8%

CLYMN/A

Net Income (TTM)

CBIO$-167M

CLYM$-58M

FCF (TTM)

CBIO$-154M

CLYM$-53M

EPS (TTM)

CBIO-$5.47

CLYM-$0.76

ROE (TTM)

CBIO-10026.0%

CLYM-3179.0%

ROA (TTM)

CBIO-8791.0%

CLYM-3079.0%

ROIC (TTM)

CBIO-10026.0%

CLYM-3179.0%

Cash

CBIO$172M

CLYM$44M

Debt

CBIO$0

CLYM$0

Net Cash/Debt

CBIO$172M

CLYM$44M

Current Ratio (TTM)

CBIO9.66x

CLYM31.45x

Quick Ratio (TTM)

CBIO9.26x

CLYM30.86x

Debt/Equity (TTM)

CBIO0.00x

CLYM0.00x

Debt/Assets (TTM)

CBIO0.0%

CLYM0.0%

Interest Coverage (TTM)

CBION/A

CLYMN/A

Net Debt/EBITDA (TTM)

CBIO0.00x

CLYM0.00x

Beta

CBIO1.39

CLYM-0.01

52W Performance

CBIO23.6%

CLYM511.1%

YTD Performance

CBIO34.6%

CLYM193.3%

% from 52W High

CBIO-45.6%

CLYM-40.0%

% from 52W Low

CBIO71.0%

CLYM572.8%

Asset Turnover (TTM)

CBIO0.05x

CLYM0.00x

FCF Yield (TTM)

CBIO-28.9%

CLYM-8.4%

Earnings Yield (TTM)

CBIO-31.4%

CLYM-9.1%

Dividend Yield (TTM)

CBION/A

CLYMN/A

Rule of 40

CBIO-1,292.8

CLYM0.0

EV/GP/RG

CBION/A

CLYMN/A

Ticker research

View CBIO research View CLYM research

Metric	CBIO Crescent Biopharma Inc	CLYM Climb Bio Inc
Market & Valuation
Market Cap	$532M	$630M
Enterprise Value	$360M	$586M
Price	$14.91	$11.00
P/E Ratio	N/A	N/A
P/S Ratio	44.76x	0.00x
EV/Sales	30.32x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.26x	2.62x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.35x	-11.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$12M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-15.7%	27.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1355.3%	0.0%
Net Margin (TTM)	-1406.4%	0.0%
FCF Margin (TTM)	-1292.8%	N/A
Net Income (TTM)	$-167M	$-58M
FCF (TTM)	$-154M	$-53M
EPS (TTM)	-$5.47	-$0.76
ROE (TTM)	-10026.0%	-3179.0%
ROA (TTM)	-8791.0%	-3079.0%
ROIC (TTM)	-10026.0%	-3179.0%
Financial Health
Cash	$172M	$44M
Debt	$0	$0
Net Cash/Debt	$172M	$44M
Current Ratio (TTM)	9.66x	31.45x
Quick Ratio (TTM)	9.26x	30.86x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	-0.01
52W Performance	23.6%	511.1%
YTD Performance	34.6%	193.3%
% from 52W High	-45.6%	-40.0%
% from 52W Low	71.0%	572.8%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.00x
FCF Yield (TTM)	-28.9%	-8.4%
Earnings Yield (TTM)	-31.4%	-9.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,292.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CBIO research	View CLYM research

Valuation

P/S Ratio

CLYM

0.00x

CBIO

44.76x

EV/FCF

CLYM

-11.04x

CBIO

-2.35x

Growth & revenue

Forward Revenue Growth

CLYM

27.3%

CBIO

-15.7%

Profitability & performance

Gross Margin

CBIO

0.0%

CLYM

0.0%

ROE

CLYM

-3179.0%

CBIO

-10026.0%

FCF Yield %

CLYM

-8.4%

CBIO

-28.9%

52-Week Performance

CLYM

511.1%

CBIO

23.6%

Detailed metrics comparison

CBIO

Crescent Biopharma Inc

CLYM

Climb Bio Inc

Market Cap

CBIO$532M

CLYM$630M

Enterprise Value

CBIO$360M

CLYM$586M

Price

CBIO$14.91

CLYM$11.00

P/E Ratio

CBION/A

CLYMN/A

P/S Ratio

CBIO44.76x

CLYM0.00x

EV/Sales

CBIO30.32x

CLYM0.00x

EV/EBITDA

CBIO0.00x

CLYM0.00x

P/B Ratio

CBIO3.26x

CLYM2.62x

P/FCF Ratio

CBION/A

CLYMN/A

EV/FCF

CBIO-2.35x

CLYM-11.04x

PEG Ratio

CBION/A

CLYMN/A

Forward P/E (NTM)

CBION/A

CLYMN/A

Forward P/S (NTM)

CBION/A

CLYMN/A

Revenue (TTM)

CBIO$12M

CLYM$0

Revenue Growth (YoY)

CBION/A

CLYMN/A

Forward Rev Growth

CBIO-15.7%

CLYM27.3%

Gross Margin (TTM)

CBIO0.0%

CLYM0.0%

Operating Margin (TTM)

CBIO0.0%

CLYM0.0%

EBITDA Margin (TTM)

CBIO-1355.3%

CLYM0.0%

Net Margin (TTM)

CBIO-1406.4%

CLYM0.0%

FCF Margin (TTM)

CBIO-1292.8%

CLYMN/A

Net Income (TTM)

CBIO$-167M

CLYM$-58M

FCF (TTM)

CBIO$-154M

CLYM$-53M

EPS (TTM)

CBIO-$5.47

CLYM-$0.76

ROE (TTM)

CBIO-10026.0%

CLYM-3179.0%

ROA (TTM)

CBIO-8791.0%

CLYM-3079.0%

ROIC (TTM)

CBIO-10026.0%

CLYM-3179.0%

Cash

CBIO$172M

CLYM$44M

Debt

CBIO$0

CLYM$0

Net Cash/Debt

CBIO$172M

CLYM$44M

Current Ratio (TTM)

CBIO9.66x

CLYM31.45x

Quick Ratio (TTM)

CBIO9.26x

CLYM30.86x

Debt/Equity (TTM)

CBIO0.00x

CLYM0.00x

Debt/Assets (TTM)

CBIO0.0%

CLYM0.0%

Interest Coverage (TTM)

CBION/A

CLYMN/A

Net Debt/EBITDA (TTM)

CBIO0.00x

CLYM0.00x

Beta

CBIO1.39

CLYM-0.01

52W Performance

CBIO23.6%

CLYM511.1%

YTD Performance

CBIO34.6%

CLYM193.3%

% from 52W High

CBIO-45.6%

CLYM-40.0%

% from 52W Low

CBIO71.0%

CLYM572.8%

Asset Turnover (TTM)

CBIO0.05x

CLYM0.00x

FCF Yield (TTM)

CBIO-28.9%

CLYM-8.4%

Earnings Yield (TTM)

CBIO-31.4%

CLYM-9.1%

Dividend Yield (TTM)

CBION/A

CLYMN/A

Rule of 40

CBIO-1,292.8

CLYM0.0

EV/GP/RG

CBION/A

CLYMN/A

Ticker research

View CBIO research View CLYM research

Metric	CBIO Crescent Biopharma Inc	CLYM Climb Bio Inc
Market & Valuation
Market Cap	$532M	$630M
Enterprise Value	$360M	$586M
Price	$14.91	$11.00
P/E Ratio	N/A	N/A
P/S Ratio	44.76x	0.00x
EV/Sales	30.32x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.26x	2.62x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.35x	-11.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$12M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-15.7%	27.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1355.3%	0.0%
Net Margin (TTM)	-1406.4%	0.0%
FCF Margin (TTM)	-1292.8%	N/A
Net Income (TTM)	$-167M	$-58M
FCF (TTM)	$-154M	$-53M
EPS (TTM)	-$5.47	-$0.76
ROE (TTM)	-10026.0%	-3179.0%
ROA (TTM)	-8791.0%	-3079.0%
ROIC (TTM)	-10026.0%	-3179.0%
Financial Health
Cash	$172M	$44M
Debt	$0	$0
Net Cash/Debt	$172M	$44M
Current Ratio (TTM)	9.66x	31.45x
Quick Ratio (TTM)	9.26x	30.86x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	-0.01
52W Performance	23.6%	511.1%
YTD Performance	34.6%	193.3%
% from 52W High	-45.6%	-40.0%
% from 52W Low	71.0%	572.8%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.00x
FCF Yield (TTM)	-28.9%	-8.4%
Earnings Yield (TTM)	-31.4%	-9.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,292.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CBIO research	View CLYM research